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In previous studies (1) we reported that
eysteine and glutathione showed a capacity to
inactivate patch test reactions in chromate-
sensitive patients. Protection against the chro-
mate reaction afforded by glutathione and
cysteinc was based upon the protection of
sulfhydryl groups which are inactivated by
chromium salts. The instability and costs of
these agents obviated their practical use.
We also showed that EDTA (edathamil
calcium-disodium) did not inactivate the hexa
valent chromium ion in patch tests performed
on chromate-sensitive subjects. The reason is
that hexavalent chromium does not react at all
with EDTA; on the other hand Cr111 can be
easily joined with EDTA. There is little if any
evidence that trivalent chromium is a sensitizing
agent (2, 3, 4). We confirmed the incapability of
trivalent chromium to sensitize a group of twelve
patients with proved dichromate sensitivity.
These patients were patch-tested with two tri-
valent chromium compounds, basic chromium
sulfatet and chromium nitrate. All patients
showed negative patch tests with the trivalent
compounds while exhibiting positive reactions
with the hexavalent compound (5). These re-
sults showed that no antigenic similarity exists
between trivalent and hexavalent chrome and
no cross-sensitivity occurs.
Since hexavalent chromium is the agent
capable of producing specific epidermal sensitiza-
tion, we thought that protection against the
hexavalent chromium reaction could be ac-
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complished if the Cry1 were reduced to the
Cr111 form. Since the latter could readily be
chelated, complete inactivation of both Cryj
and Cr111 would result. Although trivalent
chromium ions are slow in their reactions with
various complexing agents, once formed, the
complexes are extremely stable.
Attention was directed to an agent which
could convert hexavalent chromium to trivalent
chromium with subsequent chelation without
irritating the skin. Our studies have shown that
sodium pyrosulfite was well suited as a reducing
agent and that tartaric acid could serve as the
chelating agent. In combination with glucose
and ammonium chloride these chemicals have
been compounded into an agent against chro-
mium.
The anti-chrome reagent consisted of the
following quantities:
Sodium pyrosulfite
Tartarie acid
Glucose
2 parts/wt.
1 part/wt.
1 part/wt.
1 pnrt/wt.Ainmonium Chloride
1 gm. of the anti-chrome reagent contains
sufficient sodium pyrosulfite to reduce 100,000
'y of Cry1 to Cr111; the tartaric acid in this
amount of anti-chrome is sufficient to ehelate
the resultant Cr111. For clinical use, the anti-
chrome reagent was used in a 10% concentration
either in ointment base (earbowax or hydro-
philie ointment) or in aqueous solution.
The following formulas explain the reduction
and chelation reactions with Cry1 and Cr111.
1) 2 Cr1O + 3S2O + 5 H10 = Cr +
6SO + 10 0H
2) + 1H1C4H405 = Cr (HC4H4O5)1 +1H
The chelation reaction of tartarie acid with
trivalent chromium (6) may also be explained
as follows:
6 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
0
L0H
H——0HCr+3
H—C—OH
—OH
0 H H 0
() (I)/HH/ -—-——OH H00
__
C=O/
HO—C—C—C—C—O HO—C—H
HO—CL--H
The function of the ammonium chloride is to
render the system slightly acidic (pH = 4). The
glucose aids in the reduction of hexavalent
chromium.
By means of patch tests on chromate-sensitive
subjects we have shown that in 10% concentra-
tions our anti-chrome reagent in ointment or
solution completely prevented the allergic re-
action. The ointment bases and plain water
were used as controls (Figs. 1, 2, 3, 4).
METHOD
In order to determine the effect of the anti-
chrome ointment and solution after the skin
had been in contact with 0.25% potassium
diehromate, the following procedure was per-
formed on two chromate-sensitive patients:
Twelve closed patches of 0.25% potassium
diehromate were applied respectively to the left
and right sides of the back. After varying in
Fio. 1. Testing method, for chromium sensitivity
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Fic. 2. (Patient F. K.) 48 hours reaeing demonstrates the following:
Test 1: 3 plus reaction (Cryi: potassium dichromate 0.25%).
Test 2: Negative (Cr111: chromium nitrate 0.25%).
Test 3: Negative (Crux: basic chromium sulfate 0.2%).
Test 4: plus reaction—control (carbowax) over which a patch test with 02.5% K2CrO7 was applied.
Test 5: 3 plus reaction—control base (hydrophilic ointment over which a patch test with 0.25%
K2CrO7 was applied.
Test 6: Negative—anti-chrome ointment (carbowax base) over which a patch test with 0.25% K2CrO7
was applied.
Test 7: Negative—anti-chrome ointment (hydrophilic ointment base) over which a patch test with
0.25% &Cr07 was applied.
Test 8: 3 plus reaction—control of linen soaked in water over which a patch test with 025% K2CrO7
was applied.
Test 9: Negative—linen soaked in anti-chrome solution over which a patch test with 025% K2CrO7
was applied.(There is a moderate amount of adhesive tape reaction in this case).
tervals of time, each horizontal line of patches
was successively removed, the contact areas on
the left side were rubbed with the antichrome
ointment (a, b, c, d, c, f) and the control base
(a', b', c', d', e', f') and left uncovered. The
anti-chrome solution (g, h, i, j, k, 1) and water
(g', h', i', j', k', 1') were used in a similar manner
for the patches on the right side. rrhc first group
of four patches was removed after 15 minutes;
the anti-chrome ointment and solution and their
controls were applied; the second group of four
patches after 30 minutes; the third group after
an hour; the fourth group after two hours; the
fifth group after three hours; and the sixth
group after six hours. Readings were made after
each successive removal of the patches and a
final reading after 24—30 hours. In addition, 10
patches of 0.25% potassium dichromate were
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FIG. 3. Five day reading on same patient. Positive reactions have persisted; no change at the site
of the negative reactions.
applied in a vertical line down the center of the
back. These patches were removed after varying
intervals of time and the sites of contact were
washed with pledgets of cotton soaked in 1%
sodinm lanryl sulfate solution. The first patch
was removed after 15 minutes, the second after
30 minutes, and the remaining 8 patches at 5
minute intervals. The results of this study are
given in Charts 1, 2 and Figures 5, 6.
RESULTS
1. Trivalent chromium compounds caused no
reactions on dichromate-sensitive patients.
2. An anti-chrome reagent of sodium pyro-
sulfite, tartarie acid, glucose, and ammonium
chloride completely prevented patch test re-
actions in chromate-sensitive patients if applied
to the skin before the application of 0.25%
potassium dichromate.
3. In chromate-sensitive patients contact with
0.25% potassium dichromate for 15 minutes or
less will elicit the cczematous reaction.
4. Washing with sodium lauryl sulfate up to
15 minutes will prevent the reaction; no inhibi-
tion occurs if the washing procedure is used at
later time intervals.
5. The application of anti-chrome ointment
on two chromate-sensitive patients after 15 and
30 minutes blocked reactions over sites of con-
tact with 0.25% potassium dichrom ate; applica-
tion of the control ointment base produced min-
imal blockage at 15 minutes and no effect at 30
minutes. After 30 minutes, all blocking attempts
proved ineffective.
6. Anti-chrome solution and the water control
prevented a reaction if applied within 15 minutes
after contact with 0.25% potassium dichromate;
neither showed any blocking effect by 30 minutes.
7. The earliest clinical manifestation of
*1 C
r
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FIG. 4. (Patient J. O. 48 hours reading. The patch test results on this patient are similar to those
described in Fig. 2.
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* Denotes removal of patch.
CHART 1. The effects of anti-chrome mixtures and their controls used after varying periods of time
following contact with 0.25% potassium dichromate. Sites a to 1 treated with anti-chrome prepara-
tions; a' to 1' controls.
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Fio. 5. The application of anti-chrome ointment blocked reactions at sites of contact at 15 and 30
minutes (a and b), control ointment base produced minimal blockage at 15 minutes (a') and no effect
at 30 minutes (b'). After 30 minutes, all blocking attempts proved ineffective (c to f). Anti-chrome
solution and the water control prevented reaction at sites of contact with 0.25% potassium dichromate
when applied within 15 minutes (g and g'); neither showed any blocking effect by 30 minutes (h and h').
.1'
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Fm. 6. Washing with sodium lauryl sulfate within 15 minutes after contact prevented allergic reac-
tion; no inhibition of allergic reaction occurred if washing with sodium lauryl sulfate solution is ap-
plied after 15 minutes.
,,!t \
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state with subsequent chelation, capable of
inactivating patch test reactions in ehromate-
sensitive patients, was described.
These findings open a practical approach to
the prophylactic management of chromate
dermatitis. Current studies are being conducted
in various industries to determine tbe usefulness
of this reagent under actual working conditions.
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Patch
Time Intervals for
Removal of Patch
15 minutes
30 minutes
35 minutes
40 minutes
45 minutes
50 minutes
55 minutes
60 minutes
65 minutes
70 minutes
Reaction Reaction AfterAfter 6 24 HoorsHours
- +/+2
- +2
- +2
+2
+1+2
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CHART 2. Effect of sodium lauryl sulfate wash-
ing at varying intervals of time following contact
with 0.25% potassium dichromate.
cczematization was observed after 6 hours
following contact with the sensitizer.
CONCLUSIONS
An anti-ebrotne reagent based on the reduc-
tion of hexavalcnt chromium to the trivalent
